Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Quarterly results
Appointed director
ARADIGM CORP (ARDM) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/29/2020 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/29/2020 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
06/15/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "3929 Point Eden Way, Hayward, California Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) Securities registered pursuant to Section 12 of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common ARDMQ OTC Pink Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of ...",
"Aradigm Announces Effective Date of Modified Combined Chapter 11 Plan and Disclosure Statement"
06/04/2020 8-K Other Events
04/30/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "3929 Point Eden Way, Hayward, California Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) Securities registered pursuant to Section 12 of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common ARDMQ OTC Pink Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of ...",
"Aradigm Announces Conditional Approval for the Combined Chapter 11 Plan and Disclosure Statement"
04/13/2020 8-K Other Events
Docs: "Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) Securities registered pursuant to Section 12 of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common ARDMQ OTC Pink Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933..."
04/03/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) Securities registered pursuant to Section 12 of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common ARDMQ OTC Pink Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933...",
"Aradigm Announces Sale of Assets to Grifols, S.A."
03/09/2020 8-K Quarterly results
02/21/2020 8-K Quarterly results
10/30/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) Securities registered pursuant to Section 12 of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common ARDMQ OTCC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or ...",
"Aradigm Announces Withdrawal of European Marketing Authorization Application for Linhaliq Newark Calif., October 30, 2019 - - Aradigm Corporation today announced that following a recent Oral Explanation, it has withdrawn its Marketing Authorization Application for Linhaliq as a treatment for non-cystic fibrosis bronchiectasis patients with chronic lung infections with Pseudomonas aeruginosa . The decision follows recent interactions with the European Medicines Agency Committee for Medicinal Products for Human Use , during which the Company learned that the CHMP was likely to formally adopt a negative opinion in its evaluation of the application. On February 15, 2019, Aradigm filed a petition for bankruptcy protection under Chapter 11 of the United States Bankruptcy Code in the United Stat..."
10/22/2019 RW Form RW - Registration Withdrawal Request:
10/21/2019 8-K Other Events, Financial Statements and Exhibits
Docs: "Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions : ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under the Exchange Act ) Securities registered pursuant to Section 12 of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common ARDMQ OTCC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or ...",
"Aradigm Receives Feedback Following an Oral Explanation with the European Medicines Agency Newark Calif., October 21, 2019—— Aradigm Corporation today announced that following a recent Oral Explanation, it has received feedback that a negative opinion is likely to be received in November 2019 from the CHMP , a committee of the European Medicines Agency , for the centralized marketing authorization application for Linhaliq as a treatment for non-cystic fibrosis bronchiectasis patients with chronic lung infections with Pseudomonas aeruginosa . On February 15, 2019, Aradigm filed a petition for bankruptcy protection under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the Northern District of California, Case no. 19-40363. Information regarding Arad..."
09/05/2019 SC 13D Bleichroeder LP reports a 26.5% stake in Aradigm Corporation
09/05/2019 3 Bleichroeder LP (10% Owner) has filed a Form 3 on ARADIGM CORP
09/04/2019 4 First Eagle Investment Management, LLC (10% Owner) has filed a Form 4 on ARADIGM CORP
Txns: Disposed of 3,375,523 shares @ $0
Disposed of 259,117 options to buy @ $0
Disposed of 3,362,072 options to buy @ $0
09/04/2019 SC 13D/A First Eagle Investment Management, LLC reports a 0% stake in Aradigm Corporation
06/10/2019 8-K Entry into a Material Definitive Agreement
05/03/2019 4 First Eagle Investment Management, LLC (10% Owner) has filed a Form 4 on ARADIGM CORP
Txns: Acquired 85,997 options to buy @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy